Plain-English translation of NCT05478213 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial tests a specialized catheter called a monophasic action potential (MAP) catheter during heart rhythm ablation procedures. The MAP catheter records detailed electrical information from your heart muscle that standard catheters cannot capture. Researchers believe this new information will help doctors identify and treat dangerous heart rhythms more successfully.
Current ablation procedures for abnormal heart rhythms have only modest success rates, and many patients experience the problem again or the procedure doesn't work. This study aims to solve that problem by using the MAP catheter to get a better 'map' of what's causing the dangerous rhythm, so doctors can treat it more effectively.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo your standard ventricular tachycardia ablation procedure as planned. During this procedure, doctors will also use the MAP catheter alongside their regular tools to record electrical information from your heart muscle. The MAP catheter is similar to catheters already used in ablation and will not change or interrupt your treatment — it simply gathers additional research data.
AI-generated summary from trial data · Sep 5, 2026 · Not medical advice
United States